APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Immunoglobulin (IVIg)

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Selected research

Market Structure

Global Intravenous Immunoglobulin (IVIg) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchIntravenous Immunoglobulin (IVIg) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Immunoglobulin (IVIg) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intravenous Immunoglobulin (IVIg) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Immunoglobulin (IVIg) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

This report provides an overview of the global Intravenous Immunoglobulin (IVIg) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Intravenous Immunoglobulin (IVIg) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Immunoglobulin (IVIg) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Immunoglobulin (IVIg) market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Immunoglobulin (IVIg) Segment by Company

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg) Segment by Type

IVIg Liquid

IVIg Powder

Intravenous Immunoglobulin (IVIg) Segment by Application

Immunodeficiency

Autoimmune Disease

Acute Infection

Intravenous Immunoglobulin (IVIg) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Immunoglobulin (IVIg) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intravenous Immunoglobulin (IVIg) Industry Trends Table 2. Intravenous Immunoglobulin (IVIg) Industry Drivers Table 3. Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges Table 4. Intravenous Immunoglobulin (IVIg) Industry Restraints Table 5. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (K Bottle) & (2021-2026) Table 8. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers Table 9. Global Intravenous Immunoglobulin (IVIg) Average Sales Price (USD/Bottle) of Manufacturers (2021-2026) Table 10. Global Intravenous Immunoglobulin (IVIg) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intravenous Immunoglobulin (IVIg) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intravenous Immunoglobulin (IVIg) Manufacturers, Product Type & Application Table 13. Global Intravenous Immunoglobulin (IVIg) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Immunoglobulin (IVIg) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IVIg Liquid Table 17. Major Manufacturers of IVIg Powder Table 18. Global Intravenous Immunoglobulin (IVIg) Sales by Type 2021 VS 2025 VS 2032 (K Bottle) Table 19. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 20. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 21. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026) Table 22. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2027-2032) Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue by Type 2021 VS 2025 VS 2032 (K Bottle) Table 24. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (K Bottle) Table 25. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (K Bottle) Table 26. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2026) Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Immunodeficiency Table 29. Major Manufacturers of Autoimmune Disease Table 30. Major Manufacturers of Acute Infection Table 31. Global Intravenous Immunoglobulin (IVIg) Sales by Application 2021 VS 2025 VS 2032 (K Bottle) Table 32. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 33. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 34. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026) Table 35. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2027-2032) Table 36. Global Intravenous Immunoglobulin (IVIg) Revenue by Application 2021 VS 2025 VS 2032 (K Bottle) Table 37. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (K Bottle) Table 38. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (K Bottle) Table 39. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2026) Table 40. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2027-2032) Table 41. Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032 (K Bottle) Table 42. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle) Table 43. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2026) Table 44. Global Intravenous Immunoglobulin (IVIg) Sales Forecasted by Region (2027-2032) & (K Bottle) Table 45. Global Intravenous Immunoglobulin (IVIg) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Bottle) Table 47. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 48. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 49. Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Bottle) Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 52. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Bottle) Table 53. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 54. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 55. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Bottle) Table 56. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 57. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 58. Global Intravenous Immunoglobulin (IVIg) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2026) Table 62. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2027-2032) Table 63. Baxter Company Information Table 64. Baxter Business Overview Table 65. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio Table 67. Baxter Recent Development Table 68. Grifols Company Information Table 69. Grifols Business Overview Table 70. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio Table 72. Grifols Recent Development Table 73. CSL Company Information Table 74. CSL Business Overview Table 75. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CSL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 77. CSL Recent Development Table 78. Octapharma Company Information Table 79. Octapharma Business Overview Table 80. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio Table 82. Octapharma Recent Development Table 83. Biotest Company Information Table 84. Biotest Business Overview Table 85. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio Table 87. Biotest Recent Development Table 88. Kedrion Company Information Table 89. Kedrion Business Overview Table 90. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio Table 92. Kedrion Recent Development Table 93. Hualan Bio Company Information Table 94. Hualan Bio Business Overview Table 95. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio Table 97. Hualan Bio Recent Development Table 98. CNBG Company Information Table 99. CNBG Business Overview Table 100. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio Table 102. CNBG Recent Development Table 103. Shanghai RAAS Company Information Table 104. Shanghai RAAS Business Overview Table 105. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio Table 107. Shanghai RAAS Recent Development Table 108. CBPO Company Information Table 109. CBPO Business Overview Table 110. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio Table 112. CBPO Recent Development Table 113. LFB Group Company Information Table 114. LFB Group Business Overview Table 115. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio Table 117. LFB Group Recent Development Table 118. BPL Company Information Table 119. BPL Business Overview Table 120. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. BPL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 122. BPL Recent Development Table 123. Sichuan Yuanda Shuyang Company Information Table 124. Sichuan Yuanda Shuyang Business Overview Table 125. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio Table 127. Sichuan Yuanda Shuyang Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Intravenous Immunoglobulin (IVIg) Distributors List Table 131. Intravenous Immunoglobulin (IVIg) Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Intravenous Immunoglobulin (IVIg) Product Image Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Immunoglobulin (IVIg) Sales (2021-2032) & (K Bottle) Figure 5. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) & (2021-2032) Figure 6. Global Top 5 and 10 Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IVIg Liquid Image Figure 9. IVIg Powder Image Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021 VS 2025 VS 2032) & (K Bottle) Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2032) Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021 VS 2025 VS 2032) & (K Bottle) Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2032) Figure 16. Immunodeficiency Image Figure 17. Autoimmune Disease Image Figure 18. Acute Infection Image Figure 19. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021 VS 2025 VS 2032) & (K Bottle) Figure 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2032) Figure 22. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021 VS 2025 VS 2032) & (K Bottle) Figure 23. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2032) Figure 25. North America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 26. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2032) Figure 27. U.S. Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 28. Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 29. Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 30. Europe Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 31. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2032) Figure 32. Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 33. France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 34. U.K. Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 35. Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 36. Netherlands Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 37. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 38. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2032) Figure 39. China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 40. Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 41. South Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 42. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 43. India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 44. Australia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 45. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 46. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2032) Figure 47. Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 48. South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 49. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 50. Turkey Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 51. Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 52. UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 53. Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 54. Chile Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2021-2032) & (K Bottle) Figure 55. Global Intravenous Immunoglobulin (IVIg) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Figure 58. North America Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Intravenous Immunoglobulin (IVIg) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Intravenous Immunoglobulin (IVIg) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
Companies covered
  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous Immunoglobulin (IVIg) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intravenous Immunoglobulin (IVIg) Market Dynamics
  1. 2.1 Intravenous Immunoglobulin (IVIg) Industry Trends
  2. 2.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
  3. 2.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
  4. 2.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
3 Intravenous Immunoglobulin (IVIg) Market by Manufacturers
  1. 3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Immunoglobulin (IVIg) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Immunoglobulin (IVIg) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Immunoglobulin (IVIg) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intravenous Immunoglobulin (IVIg) Manufacturers, Product Type & Application
  7. 3.7 Global Intravenous Immunoglobulin (IVIg) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Immunoglobulin (IVIg) Tier 1, Tier 2, and Tier 3
4 Intravenous Immunoglobulin (IVIg) Market by Type
  1. 4.1 Intravenous Immunoglobulin (IVIg) Type Introduction
  2. 4.1.1 IVIg Liquid
  3. 4.1.2 IVIg Powder
  4. 4.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type
  5. 4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032)
  7. 4.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
  9. 4.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032)
  11. 4.3.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2032)
5 Intravenous Immunoglobulin (IVIg) Market by Application
  1. 5.1 Intravenous Immunoglobulin (IVIg) Application Introduction
  2. 5.1.1 Immunodeficiency
  3. 5.1.2 Autoimmune Disease
  4. 5.1.3 Acute Infection
  5. 5.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application
  6. 5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032)
  8. 5.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Application
  10. 5.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032)
  12. 5.3.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2032)
6 Global Intravenous Immunoglobulin (IVIg) Sales by Region
  1. 6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026)
  4. 6.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intravenous Immunoglobulin (IVIg) Revenue by Region
  1. 7.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region
  2. 7.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026)
  4. 7.1.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2027-2032)
  5. 7.1.4 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intravenous Immunoglobulin (IVIg) Revenue (2021-2032)
  8. 7.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intravenous Immunoglobulin (IVIg) Revenue (2021-2032)
  11. 7.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter
  2. 8.1.1 Baxter Company Information
  3. 8.1.2 Baxter Business Overview
  4. 8.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
  6. 8.1.5 Baxter Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 CSL
  14. 8.3.1 CSL Company Information
  15. 8.3.2 CSL Business Overview
  16. 8.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
  18. 8.3.5 CSL Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Biotest
  26. 8.5.1 Biotest Company Information
  27. 8.5.2 Biotest Business Overview
  28. 8.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
  30. 8.5.5 Biotest Recent Developments
  31. 8.6 Kedrion
  32. 8.6.1 Kedrion Company Information
  33. 8.6.2 Kedrion Business Overview
  34. 8.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
  36. 8.6.5 Kedrion Recent Developments
  37. 8.7 Hualan Bio
  38. 8.7.1 Hualan Bio Company Information
  39. 8.7.2 Hualan Bio Business Overview
  40. 8.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
  42. 8.7.5 Hualan Bio Recent Developments
  43. 8.8 CNBG
  44. 8.8.1 CNBG Company Information
  45. 8.8.2 CNBG Business Overview
  46. 8.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
  48. 8.8.5 CNBG Recent Developments
  49. 8.9 Shanghai RAAS
  50. 8.9.1 Shanghai RAAS Company Information
  51. 8.9.2 Shanghai RAAS Business Overview
  52. 8.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
  54. 8.9.5 Shanghai RAAS Recent Developments
  55. 8.10 CBPO
  56. 8.10.1 CBPO Company Information
  57. 8.10.2 CBPO Business Overview
  58. 8.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
  60. 8.10.5 CBPO Recent Developments
  61. 8.11 LFB Group
  62. 8.11.1 LFB Group Company Information
  63. 8.11.2 LFB Group Business Overview
  64. 8.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
  66. 8.11.5 LFB Group Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Sichuan Yuanda Shuyang
  74. 8.13.1 Sichuan Yuanda Shuyang Company Information
  75. 8.13.2 Sichuan Yuanda Shuyang Business Overview
  76. 8.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
  78. 8.13.5 Sichuan Yuanda Shuyang Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
  2. 9.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Immunoglobulin (IVIg) Production Mode & Process
  6. 9.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Immunoglobulin (IVIg) Distributors
  9. 9.2.3 Intravenous Immunoglobulin (IVIg) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst